Article
Correlated Motions and Dynamics in Different Domains of Epidermal Growth Factor Receptor With L858R and T790M Mutations.
IEEE/ACM transactions on computational biology and bioinformatics - 1 Jan 2000
Qureshi Rizwan, Ghosh Avirup, Yan Hong
Abstract excerpt
Non-small cell lung cancer with an activating epidermal growth factor receptor (EGFR) mutation responds well to targeted drugs. In most cases, drug resistance appears after about a year. Several studies have been conducted on the kinase domain of EGFR to understand the drug resistance mechanism. Since EGFR is a multi-domain protein, mutation in the kinase domain may affect the other domains as well. In this...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
